2026 NPPES data Legal Medicine NPI 1043432925 M.D.
Verify on CMS →

MARK BARTISS, M.D.

Legal Medicine in MANAHAWKIN, New Jersey. CMS National Plan and Provider Enumeration System profile including specialty classification, practice address, and Medicare prescribing data when reported.

Federal data — no proprietary rating. PlainDoctor publishes the actual CMS NPPES and Medicare records — NPI registration, specialty, practice location, and prescribing data — without a composite score or editorial opinion on top. Every field traces to a federal source.
Prescribing volume
1K
Medicare Part D claims · 188 beneficiaries · Legal Medicine avg: 3K
Generic prescribing
93%
generic claims · 7% brand-name · higher generic rates reduce patient out-of-pocket costs
What the federal data reveals: MARK BARTISS, M.D. is a Legal Medicine ([object Object]) practicing in MANAHAWKIN, New Jersey with a Medicare Part D prescribing footprint of 1K claims across 188 beneficiaries — 7% brand-name prescribing .

What stands out: MARK BARTISS, M.D. filed 1,167 Medicare Part D claims in 2023 across MANAHAWKIN, New Jersey. Every figure on this page comes straight from federal CMS records, with no proprietary rating applied.

MARK BARTISS, M.D. at a glance

Quality data not reported

NPI registry status

Active

Issued 05/02/2007

NPI 1043432925

Primary specialty

Legal Medicine

Niche

1,067 US NPIs in this specialty

Medicare Part D claims

1,167 59% vs specialty avg

2023 prescription claims

Specialty avg: 2,821

Specialty distribution in New Jersey

How Legal Medicine compares to other specialties among New Jersey providers

New Jersey providers

Legal Medicine share within New Jersey

1. Legal Medicine42%2. Internal medicine21%3. Family medicine17%4. Surgical12%5. Pediatric8%
Legal Medicine share within New Jersey

Specialty board-certification context

Estimated specialty board-certified rate — Legal Medicine (ABMS / AOA reference)

Quality data not reported
Est. board-certified rate
78%
Legal Medicine ABMS/AOA estimate

Est. board-certified rate (Legal Medicine) — ABMS / AOA estimate

0%100%78%
Est. board-certified rate (Legal Medicine) — ABMS / AOA estimate

The Merit-based Incentive Payment System (MIPS) scores providers 0–100 across four performance categories: Quality, Cost, Promoting Interoperability, and Improvement Activities, weighted under 42 CFR §414.1380. Reporting is voluntary for many small practices, so absence of a MIPS score is not a quality signal.

Board certification through an ABMS or AOA member board signals voluntary post-licensure examination plus continuous Maintenance of Certification cycles. Verify any individual provider's status through certificationmatters.org (ABMS) or osteopathic.org (AOA).

MARK BARTISS, M.D. is a Legal Medicine provider practicing in MANAHAWKIN, New Jersey, according to the CMS National Plan and Provider Enumeration System (NPPES). Credentials: M.D.. NPI: 1043432925. This profile includes practice location, specialty classification, and organizational affiliations from the CMS provider registry. Provider information is self-reported to CMS and updated monthly.

MARK BARTISS, M.D. appears in the CMS NPPES registry as a Legal Medicine provider holding M.D. credentials at 24 NAUTILUS DR STE 5, MANAHAWKIN, NJ, 08050, with a listed phone of (609) 978-9002. NPI 1043432925 was issued on 05/02/2007. Because NPPES data is self-reported by the provider and refreshed monthly, the address, phone, and specialty reflect what BARTISS most recently submitted to CMS rather than a vetted directory listing, which is why patients should always confirm the practice is still at this location before scheduling.

Medicare Part D records for calendar year 2023 show 1,167 prescription claims written by this provider, covering 188 Medicare beneficiaries and totaling roughly $63K in drug spend, split 7% brand-name and 93% generic by claim count, with an opioid prescribing rate of 2.1%. These figures capture only Medicare Part D — commercial insurance, Medicaid, and cash-pay prescriptions are not included, and any drug-beneficiary cell under 11 is suppressed by CMS for patient privacy.

Legal Medicine is a narrow specialty nationwide, with 1,067 enrolled providers across 51 states and an average of 2,821 Part D claims per prescriber, so the context for interpreting these metrics differs meaningfully from a primary-care baseline. Important: PlainDoctor is a directory of publicly available government data, not medical advice, a malpractice database, or a quality rating. Inclusion here does not imply a recommendation, and absence of complaints or sanctions on this page does not mean none exist — always verify credentials through the NPPES NPI Registry, your state medical board, and the ABMS or AOA before making healthcare decisions.

Practice Address

24 NAUTILUS DR STE 5
MANAHAWKIN, NJ 08050

Provider Details

NPI 1043432925
Specialty Legal Medicine
Credentials M.D.
Gender Male
NPI Issued 05/02/2007

Brand vs generic prescribing mix · Generic-heavy

MARK BARTISS, M.D. — brand share 7.0%
Specialty average (est.)

7% brand-name claims vs 93% generic, on 1,167 2023 Medicare Part D claims.

The federal Medicare Part D Generic Dispensing Rate national benchmark sits near 90% generic / 10% brand for primary-care prescribers, per CMS Office of the Actuary 2024 estimates. Higher brand share is common in specialty prescribing where generic equivalents are not available.

Medicare Part D Prescribing Data

CMS Medicare Part D prescriber-level data for calendar year 2023.

1,167
Total Claims
$63K
Total Drug Cost
188
Medicare Beneficiaries

Prescribing Breakdown

30-Day Fills
2,599
Total Day Supply
77,063
Brand vs Generic
7% brand / 93% generic
Brand Drug Cost
$12K
Generic Drug Cost
$44K
Opioid Claims
25 (2.1% rate)
Antibiotic Claims
13

Patient Demographics

Average Patient Age
72.0 years
Avg HCC Risk Score
0.82
Gender Split
58% female / 42% male
Age Distribution
<65: 13, 65-74: 121, 75-84: 42, 85+: 12

Top Prescribed Drugs (Medicare Part D)

Top drugs by claim count for calendar year 2023. Based on Medicare Part D data only.

Drug Claims
Levothyroxine Sodium
174
Anastrozole
127
Testosterone Cypionate
107
Liothyronine Sodium
44
Gabapentin
38
Alprazolam
32
Dextroamphetamine-Amphetamine
Dextroamphetamine/Amphetamine
18
Oxycodone-Acetaminophen
Oxycodone Hcl/Acetaminophen
16
Lamotrigine Er
Lamotrigine
15
Metformin Hcl Er
Metformin Hcl
15

* Counts below 11 are suppressed by CMS for patient privacy. Generic names shown where available from CMS Part D data.

Legal Medicine Overview

How MARK BARTISS, M.D. fits within the Legal Medicine landscape nationally.

1,067
Legal Medicine Providers in US
51
States with Legal Medicine
2,821
Avg Claims per Provider

MARK BARTISS, M.D.'s 1,167 claims are below the specialty average of 2,821.

Nearby Legal Medicine Providers in New Jersey

Other clinicians with the same primary specialty enrolled in New Jersey, drawn from the same CMS NPPES roster as BARTISS.

Compare Legal Medicine nationally: see state-by-state distribution →

Frequently Asked Questions

What is MARK BARTISS, M.D.'s specialty?
MARK BARTISS, M.D. specializes in Legal Medicine and practices in MANAHAWKIN, New Jersey. Credentials: M.D..
How much does MARK BARTISS, M.D. prescribe under Medicare Part D?
In 2023, MARK BARTISS, M.D. wrote 1,167 Medicare Part D claims totaling $63K in drug costs for 188 beneficiaries.
Where is MARK BARTISS, M.D. located?
MARK BARTISS, M.D. is located at 24 NAUTILUS DR STE 5, MANAHAWKIN, NJ, 08050. Phone: (609) 978-9002.
What is MARK BARTISS, M.D.'s NPI number?
MARK BARTISS, M.D.'s National Provider Identifier (NPI) is 1043432925, issued on 05/02/2007.
Does MARK BARTISS, M.D. prescribe more brand-name or generic drugs?
MARK BARTISS, M.D.'s prescribing is 7% brand-name and 93% generic drugs by claim count, with $12K in brand drug costs.
Does MARK BARTISS, M.D. prescribe opioids?
Yes, MARK BARTISS, M.D. had 25 opioid claims in 2023 with an opioid prescribing rate of 2.1%.
How many Legal Medicine providers are there in the US?
There are 1,067 Legal Medicine providers across 51 states in the US. The average Legal Medicine provider writes 2,821 Medicare Part D claims per year.
What drugs does MARK BARTISS, M.D. prescribe most often?
Based on 2023 Medicare Part D data, MARK BARTISS, M.D.'s most frequently prescribed drugs include Levothyroxine Sodium, Anastrozole, Testosterone Cypionate. This reflects Medicare Part D prescriptions only and does not include commercial insurance or other payer types.
Does MARK BARTISS, M.D. accept Medicare?
MARK BARTISS, M.D. appears in CMS Medicare data with 1,167 Part D claims and 188 Medicare beneficiaries in 2023. Contact the provider's office directly to confirm current Medicare enrollment and accepted plans.
How can I verify MARK BARTISS, M.D.'s credentials?
MARK BARTISS, M.D.'s NPI is 1043432925 with credentials M.D.. You can verify this through the NPPES NPI Registry, check state medical board records, and confirm board certification through the ABMS or AOA.

Data Sources

Provider Directory
CMS National Plan and Provider Enumeration System (NPPES), download.cms.gov/nppes, updated monthly. Contains NPI, specialty, credentials, and practice location.
Specialty Classification
NUCC Health Care Provider Taxonomy (nucc.org), the industry standard for classifying provider specialties in Medicare and Medicaid billing.
Prescribing Data
CMS Medicare Part D Prescriber Public Use File (2023). Includes claims, drug costs, beneficiaries, and opioid prescribing rates.
Limitations
Provider data is self-reported to CMS. Prescribing data reflects Medicare Part D only and does not include commercial insurance, Medicaid, or cash prescriptions. Claims below 11 beneficiaries are suppressed by CMS for privacy.

See our complete data methodology for details on how we collect and process government data.

Data as of April 2026 (NPPES) / 2023 (Medicare Part D). Source: Centers for Medicare & Medicaid Services (CMS).

Disclaimer: Data from CMS NPPES and Medicare Part D. PlainDoctor does not rate or rank providers. Provider information is self-reported and may not be current. Always verify information directly with the provider. About · Methodology